Patent · US Active

Process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine

US9637468B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Dietmar Flubacher · Glückstadt, DE
Nicole Bieri · Zürich, CH
Murat Acemoglu · Basel, CH
Pascal Michel · Rheinfelden, CH
Rasmus Mose · Hobro, DK
Hans Stettler · Allschwil, CH
Maria Caterina Testa · Basel, CH
Joerg Brozio · Basel, CH
Frank Schaefer · Lörrach, DE

Key dates

Filing date	Oct 21, 2013
Grant date	May 2, 2017
Priority date	—
Expiry date	Oct 21, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F5/025
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention discloses improved processes for manufacturing a compound, 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine, its monohydrochloride salt and intermediates thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.